1.
Chinese Journal of Diabetes
;
(12): 475-478, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-464453
ABSTRACT
[Summary] Sodium glucose cotransporter 2 (SGLT2) inhibitors have been developed as a new antidiabetic agent .The antihyperglycemic effect of SGLT 2 inhibitors is independent of insulin secretion and insulin action .SGLT2 inhibitors improve IS and islet βcell function with the possible mechanisms of reducing glucotoxicity ,weight loss and increasing GLP‐1 response .